SCHEMBL30537230

SCHEMBL30537230

Cc1ncc(-c2nc(NC3CCN(S(=O)(=O)c4cn(C)cn4)CC3)ncc2C(F)(F)F)s1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 19/20 0.66
▸ CDK2 P24941 19/20 0.66
▸ CCND1 P24385 14/20 0.66
▸ CDK6 Q00534 14/20 0.66
▸ CDK1 P06493 14/20 0.66
▸ CCNB1 P14635 14/20 0.66
▸ CDK4 P11802 12/20 0.66
▸ CCND3 P30281 12/20 0.66
▸ CCNT1 O60563 6/20 0.66
▸ CDK7 P50613 6/20 0.66
▸ CDK9 P50750 6/20 0.66
▸ CCNH P51946 6/20 0.66
▸ MNAT1 P51948 6/20 0.66
▸ CCNB2 O95067 1/20 0.41
▸ CCNE2 O96020 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ CCNB3 Q8WWL7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25401522 1.00 CCNE1 (0.66) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL30537209 0.89 CCNE1 (0.63) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL25434977 0.89 CCNE1 (0.63) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL25433803 0.89 CCNE1 (0.63) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL25435463 0.87 CCNE1 (0.63) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL30537175 0.87 CCNE1 (0.63) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL30537160 0.87 CCNE1 (0.61) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL25434645 0.87 CCNE1 (0.61) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL25434507 0.87 CCNE1 (0.60) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL30537183 0.87 CCNE1 (0.60) CCNE1CDK2CCND1CDK6CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023172957-A1 THAIZOLE-PYRIMDIINE CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2023-09-14 — — WO claimed
WO-2023172957-A1 THAIZOLE-PYRIMDIINE CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2023-09-14 — — WO disclosed
Send feedback